Buzzing Stocks: Rowan Companies PLC (RDC), Acura Pharmaceuticals, Inc. (ACUR), Titan International Inc (TWI), GulfMark Offshore, Inc. (GLF)

Albany, New York (09/25/2014) – Rowan Companies PLC (NYSE:RDC) said that J. Kevin Bartol, Executive VP, Treasurer and the CFO has decided to leave Rowan to pursue other opportunities. He will continue to be with the company till the time a successor is finalized, and transition process is completed. As of now, Rowan has not finalized any candidate. Thomas Burke, President and the CEO of Rowan, said that the company appreciates Bartol’s dedication and his contributions in company’s success in last seven years.

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) has submitted formal dispute resolution request with the FDA. The request is related to its product for Vycavert®. It is an abuse-deterrent formulation of Acetaminophen Tablets and Hydrocodone. The FDA gave determination stating the nasal snorting abuse related to Hydrocodone with acetaminophen lacks relevance. The dispute is concerned with the FDA’s determination. Acura is availing of the appeal process which can be used when there is a disagreement on conclusion derived by a reviewing division of the FDA. The appeal is responded within 30 days.

Titan International Inc (NYSE:TWI) announced the formation of its Surgeon Advisory Board. It will have seven industry-known surgeons who are specialists in minimally invasive procedures. The Board will be headed by Dr. Dennis Fowler, Executive VP of Clinical and Regulatory Affairs. The board will help the executive management team of Titan in the development process, pre-clinical testing step and clinical testing process of SPORT™ Surgical System. They will also plan and conduct a formal training session for the surgical teams who will use the surgical system SPORT™. John Hargrove, CEO of Titan, said that the company is delighted to have such an experienced board. The knowledge, expertise and experience will be invaluable in the developmental and testing processes.

GulfMark Offshore, Inc. (NYSE:GLF) said that its Board of Directors approved a quarterly dividend of $0.25 per share in cash on its Class A common stock. It will be payable on September 26, 2014 and the record date is of September 18, 2014.

About the Author

Erica is a graduate of New York University's school of Journalism. She joined US Markets Daily as a general assignment reporter in January of 2008.

Leave A Response